Literature DB >> 6398710

On Bayesian methods for bioequivalence.

M R Selwyn, N R Hall.   

Abstract

Bayesian methods are presented for assessing bioequivalence for studies in which a new formulation and a standard are administered simultaneously, and for Latin square designs which compare two or more new formulations to a standard. Two examples illustrate the application of the methods.

Mesh:

Year:  1984        PMID: 6398710

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  7 in total

1.  Bayesian communication: a clinically significant paradigm for electronic publication.

Authors:  H P Lehmann; S N Goodman
Journal:  J Am Med Inform Assoc       Date:  2000 May-Jun       Impact factor: 4.497

2.  Evaluation of bioequivalence studies.

Authors:  A P Grieve
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. II: study in healthy volunteers.

Authors:  J Popović; R Mitić; A Sabo; M Mikov; V Jakovljević; K Daković-Svajcer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Apr-Jun       Impact factor: 2.441

4.  Using statistical equivalence testing in clinical biofeedback research.

Authors:  J P Hatch
Journal:  Biofeedback Self Regul       Date:  1996-06

5.  The short of it: abbreviating the temporal discounting procedure.

Authors:  Richard Yi; Jeffrey A Pitcock; Reid D Landes; Warren K Bickel
Journal:  Exp Clin Psychopharmacol       Date:  2010-08       Impact factor: 3.157

6.  Negligible interaction test for continuous predictors.

Authors:  Yasaman Jabbari; Robert Cribbie
Journal:  J Appl Stat       Date:  2021-02-19       Impact factor: 1.416

7.  Easy Multiplicity Control in Equivalence Testing Using Two One-sided Tests.

Authors:  Carolyn Lauzon; Brian Caffo
Journal:  Am Stat       Date:  2009-05-01       Impact factor: 8.710

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.